Ash and Innovaccer Unite to Bring At-Home Testing into AI Health Cloud

NEW YORK, NY – January 14, 2026 – In a significant move to reshape population health management, at-home care provider Ash has partnered with healthcare AI leader Innovaccer. The collaboration integrates Ash's comprehensive at-home health testing solution directly into Innovaccer’s AI-powered Galaxy platform, transforming a once-fragmented process into a unified, data-driven engine for preventive care.

This strategic alliance aims to elevate at-home diagnostic programs from standalone initiatives to a core component of enterprise healthcare architecture. For health plans, accountable care organizations (ACOs), and provider-sponsored plans, the partnership promises to streamline operations, accelerate the closure of critical care gaps, and more effectively manage population risk by bringing vital health screenings directly into members' homes.

The New Strategic Imperative for Health Plans

The healthcare landscape is rapidly shifting towards the home, a trend accelerated by the pandemic and sustained by consumer demand for convenience and accessibility. The global at-home testing market, valued at nearly $7 billion in 2024, is projected to surge past $18 billion by 2030, according to Grand View Research. This partnership is positioned to help health plans not only meet this demand but leverage it to achieve key business objectives.

Historically, health plans have struggled with the operational complexities of closing care gaps. Engaging members for essential screenings, managing disparate data from various sources, and deploying timely interventions have been persistent challenges. These initiatives often require significant IT resources to manage eligibility files and integrate results, creating bottlenecks that delay action. The collaboration between Ash and Innovaccer directly addresses these pain points.

By embedding at-home diagnostics within an existing, enterprise-grade platform, health plans can move from piloting small programs to implementing scalable, white-labeled testing infrastructure. This integration allows plans to more efficiently meet quality measures, such as HEDIS scores for colorectal cancer screening (COL), diabetes care (HBD), and kidney health evaluation (KED). Early and convenient testing helps identify chronic conditions sooner, leading to better member outcomes and potentially lower long-term costs associated with advanced disease.

"With this partnership, payors and providers can operationalize at-home testing programs as an embedded component of the quality-measures engine, rather than an add-on," said Kyle Waters, CPO at Ash. This shift is critical for payers seeking a competitive edge through improved quality scores and more accurate risk adjustment.

Unifying Diagnostics and Data with AI

The core of the partnership lies in the powerful synergy between Ash's logistical prowess and Innovaccer's data intelligence. Innovaccer's Galaxy platform is engineered to be a central nervous system for healthcare organizations, unifying data from claims, clinical records, pharmacy benefits, and labs into a single, actionable source of truth. Its AI-driven workflows help care teams predict care gaps, identify high-risk members, and automate administrative tasks.

Until now, data from at-home testing often existed in a separate silo, requiring manual effort to integrate into a member's comprehensive health record. The new integration creates a seamless data pipeline. Ash's end-to-end service—which manages everything from member outreach and kit logistics to lab processing—now feeds results directly into the Galaxy platform. This means that when a member completes an at-home A1C test for diabetes or a Fecal Immunochemical Test (FIT) for colon cancer, the results flow automatically into the same workflows that care managers and quality teams use daily.

"By integrating Ash at-home test kits directly into Galaxy’s unified workflow, we are enabling payers to take a proactive approach to member care," stated Michelle Zilisch, VP Product Payer Market at Innovaccer. "This seamless integration significantly accelerates the ability to close quality and risk gaps, ensuring payers can quickly identify and intervene with members who need timely support, ultimately improving outcomes."

This deep integration also liberates valuable IT resources. Galaxy's platform is designed to handle the complex task of transforming eligibility files automatically, allowing health plans to launch and scale testing programs much faster, a crucial advantage during time-sensitive periods like year-end quality reporting.

Bringing Preventative Care and Equity into the Home

Beyond the operational benefits for payers, the partnership holds profound implications for patient access and health equity. Traditional healthcare delivery models present numerous barriers for patients, including transportation challenges, time off from work, mobility issues, and geographical distance from facilities. These obstacles disproportionately affect rural, elderly, and underserved populations, often leading to delayed diagnoses and poorer health outcomes.

At-home testing removes many of these barriers, meeting patients where they are. The convenience of collecting a sample in the privacy of one's home can significantly increase participation rates for crucial preventive screenings. For chronic conditions like diabetes and kidney disease, regular monitoring becomes far more manageable, empowering patients to take an active role in their health.

Ash provides a comprehensive solution that includes a physician network to authorize tests in all 50 states, ensuring clinical oversight. Their white-label approach allows health plans to present a cohesive and trusted brand experience to their members, from the initial outreach to the delivery of the kit and follow-up care instructions. By connecting members to necessary follow-up care based on their test results, the integrated system closes the loop, ensuring that a test result translates into meaningful clinical action.

This proactive model of care is a fundamental shift from the reactive system many patients experience today. Instead of waiting for a member to visit a doctor, the health plan can intelligently identify an individual who is overdue for a screening, deploy an at-home kit, and have the results integrated and ready for review by a care team in a matter of days.

Navigating a Competitive and Regulated Landscape

The Ash-Innovaccer alliance does not exist in a vacuum. The at-home diagnostics market is becoming increasingly crowded, with both startups and established diagnostic giants vying for position. Companies like Labcorp and Simple HealthKit are expanding their retail presence, while others are exploring their own AI and telehealth integrations. The key differentiator for this partnership is its enterprise-first approach, focusing on deep integration into the core operational and data infrastructure of health plans.

As the volume of sensitive health data generated in the home grows, so do concerns around privacy and security. The regulatory landscape for at-home diagnostics and data sharing can be complex, with companies needing to navigate HIPAA, FDA oversight, and varying state laws. This is where the robust compliance framework of the partnership becomes a critical asset.

Innovaccer's platform is built with security at its foundation, holding certifications including HITRUST, SOC 2 Type II, and ISO 27001. By channeling the data from Ash's HIPAA-compliant testing services through this secure and governed ecosystem, the partnership offers health plans a solution designed to meet the highest standards of data protection and audit-readiness. This focus on enterprise-grade security and interoperability signals that at-home testing has matured from a consumer experiment into a reliable and indispensable tool for modern population health management.